GENOME RESEARCH LIMITED - Profile & Financials

Accounts Submitted 9 Jan 2025

Confirmation Statement Submitted 23 Jun 2025

Net assets £270.24M £1.32M 2024 year on year

Total assets £357.36M £9.97M 2024 year on year

Total Liabilities £87.12M £11.29M 2024 year on year

Charges 1

1 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Wellcome Sanger Institute Wellcome Genome Campus Hinxton Saffron Walden CB10 1SA England

Office (215 Euston Road, London, NW1 2BE)

Registered office

Telephone

0122 378 6129

Website

wellcomegenomecampus.org

Credit Report

Discover GENOME RESEARCH LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£15.36M

Increased by £1.55M (+11%)

Net Assets

£270.24M

Decreased by £1.32M (-0%)

Total Liabilities

£87.12M

Increased by £11.29M (+15%)

Turnover

£177.35M

Decreased by £11.68M (-6%)

Employees

1296

Increased by 87 (+7%)

Debt Ratio

24%

Increased by 2 (+9%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

£1.3m awarded

Show:

Investors (0)

No investor information available

Officers

9 active 51 resigned

Show resigned officers

						Status
Caroline Relton	Director	British	United Kingdom	57	26 Mar 2024	Active
Daniel Abrams	Director	British	England	70	2 Dec 2019	Active
John-arne Røttingen	Director	Norwegian	England	56	1 Jun 2024	Active
Karen Chadwick	Director	British	England	58	26 Mar 2024	Active
Mark Mccarthy	Director	British	United States	65	26 Mar 2024	Active
Matthew Newcombe-ellis	Director	British	England	40	26 Mar 2024	Active
Michael Dunn	Director	British,irish	England	56	29 Apr 2024	Active
Nadia Meliti	Secretary	Unknown	Unknown	—	7 May 2019	Active

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (1)

1 Active

The Wellcome Trust Limited, As Trustee Of The Wellcome Trust

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Voting Rights 75 To 100 Percent
Significant Influence Or Control As Trust

See All Controllers

Group Structure

THE WELLCOME TRUST LIMITED united kingdom

GENOME RESEARCH LIMITED Current Company

BASE RX LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GENOME RESEARCH TRADING LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GRL CONSTRUCTION LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

HINXTON HALL LIMITED united kingdom voting rights 25 to 50 percent

Charges

1 satisfied

Documents

Company Filings

Date	Category	Description	Document
23 Jun 2025	Confirmation Statement	Confirmation statement made on 2025-06-23 with no updates	View(3 pages)
12 May 2025	Officers	Termination of Daniel Mahony as director on 2025-05-02	View(1 page)
9 Jan 2025	Accounts	Annual accounts made up to 2024-09-30	View(55 pages)
30 Jul 2024	Officers	Termination of Cilla Snowball as director on 2024-07-18	View(1 page)
11 Jul 2024	Confirmation Statement	Confirmation statement made on 2024-06-27 with no updates	View(3 pages)